World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
All Topics Links
How India could get the Trade Deal with the US by buying oil from US and Saudis/UAE and allowing imports of non grain and non dairy agricultural products
08/28/2025
US sanctioned India with 50% tariff for buying Russian oil saying it finances RUssia's war against Ukraine and daily deadly missile strikes. ein dollar terms are now insignificant at $2-the 3 billion. In fact India is already shifting to getting more of its imports from the Middle East. India could also import additional oil from the US and make changes to import non grain and non dairy agricultural products from the US in large volumes such as almonds, walnuts, pistachios, blueberries, cherries that it's upper middle class population of 250 million could benefit from the nutritional benefits. US in its fight against the pharmaceutical companies high pricing could change laws to bring in Indian pharmaceutical products at 10-15% price above Indian prices set by the government to meet needs of its large population. In pharma product pricing India leads the whole world and this benefit would lower the cost of living in the US tremendously. Both sides would benefit in a WIn-WIn relationship in trade- THIS IS ACHIEVABLE FOR THE INTERESTS OF AMERICANS AND INDIANS. IT ONLY REQUIRES VISION OF BOTH SIDES.
Linked Articles
India's benefit from Russian oil imports exaggerated; actual gain at just $2.5 bn
The Economic Times 08/28/2025
Opinion | America’s Fearsome Farm Lobby Has Nothing on India’sThe Wall Street Journal 08/27/2025
Tech Startup Box Inc. in cloud computing- travails of co-founders Aaron Levie and Dylan Smith with the IPO process and changing market sentiment
04/19/2015
Changing market sentiment about Box Inc. consistent losses as it goes after rapid growth, with one anayst calling it "a house of horrors," a long IPO process and investor demands, have an unnerving and distracting effect on the founders. Langley and Hardy describe the experience of startup founders as competition and market perceptions change.
Linked Articles
Rich, but Not Silicon Valley Rich for Founders of Box
Wall Street Journal 04/24/2015
Box, Provider of Cloud-Computing Services, Faces Make-or-Break MomentNew York Times 04/19/2015
The new Jinping-Keqiang leadership and reducing pharmaceutical and healthcare costs to help consumers in China (1)
10/03/2012
After a decade of decline in consumer spending in favor of infrastructure spending to where it is now only 35% of GDP, or half that in the U.S. as a percentage of GDP, China's leadership realizes the need to help consumers. It is seen as high on the list of priorities for the Party's survival. Ordinary Chinese, rural households and the elderly are seriously affected by the high cost of healthcare and the need to set aside a large portion of savings for medical emergencies (Orlik). This further depresses consumer after the impact of low savings rates. With a bursting of the property bubble the money depositors shifted to real estate is also at risk for middle class investors.
Linked Articles
Wall Street Journal 10/03/2012
Politics Is a Bitter Pill for GlaxoWall Street Journal 07/25/2013
The rapid growth through acquisitions of Teva Pharmaceutical
11/23/2011
Israel's Teva Pharmaceutical is the world's largest maker of generic drugs, followed by Watson Pharmaceuticals and Novarti's Sandoz unit.
Linked Articles
Wall Street Journal 05/08/2012
Former Test-Tube Washer Built Generic-Drug Maker TevaWall Street Journal 11/23/2011
Pfizer and Merck organize R&D using international innovation hubs- 2011-2015
05/02/2011
Efforts to tap into the latest external science at universities and research centers outside company labs is leading pharmaceutical companies to try a different approach to R&D. Pfizer closed its R&D facility in Sandwich, England and opened one in Cambridge. It opened hubs in Boston, La Jolla. Merck has followed this approach with a decision to setup innovaton hubs in Boston, San Francisco, London and Shanghai.
Linked Articles
Merck Plans Radical Overhaul of Drug R&D Unit
Wall Street Journal 12/28/2013
Life Beyond Lipitor for Pfizer ChiefWall Street Journal 05/02/2011
Bill Gates and David Rieff on the untapped resource for India and the global economy of India's children
10/11/2009
The challenge of getting hundreds of millions of rural Indian children into the development mainstream through better healthcare, pharmaceuticals, nutrition, education and agricultural improvement is the next major challenge for India and the global economy. It is a huge untapped resource for India and the global economy.
Linked Articles
Bill Gates: What I Learned in the Fight Against Polio
Wall Street Journal 11/10/2013
India’s Malnutrition DilemmaNew York Times 10/11/2009
Increasing scruiny in the pharmaceutical industry
05/29/2007
Drug companies come under intense scrutiny with a chairperson of a House Committe with FDA funding oversight comparing the drug industry to the tobacco industry. Scrutiny from medical journals, congress, the media and public of controversial pricing practices, advertising, and presentation of internal study findings.
Linked Articles
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01/23/2008
Journalistic MalpracticeWall Street Journal 05/29/2007
Kamala Harris tells America it is time to build an Opportunity Economy
08/17/2024
Creating opportunities for all and taking action on the Cost of Living concerns of ordinary Americans was the theme for Kamal Harris rally in North Carolina with president Biden. There she set out her economic plan to limit grocery costs, cut housing costs and cut pharmaceuticals costs, address child care, and pave the way for an Opportunity Economy, A New America Way Forward.
Linked Articles
Remarks by Vice President Harris at a Campaign Event in Raleigh, NC | The White House
The White House 08/17/2024
Harris vows to build ‘opportunity economy’ and attacks Trump on taxThe Guardian 08/16/2024
The Jinping-Keqiang leadership in China and the need to help consumers by reducing pharmaceutical and healthcare costs (2)
05/31/2013
The particular need to help the elderly in an aging population for China. The elderly suffer most from the need to set aside a large portion of savings for healthcare costs (Orlik).
Linked Articles
Politics Is a Bitter Pill for Glaxo
Wall Street Journal 07/25/2013
Aging Chinese Face a Bleak PictureWall Street Journal 05/31/2013
Why Mario Monti is the Euro's best hope
06/24/2012
The leadership exercized by Mario Monti in Italy and supported by all Italians offers one of the best hopes for the Euro. The efforts of the mild mannered professor of political economy from Bocconi University in Milan.
Linked Articles
Italy's Leader Calls Economic Efforts "a Very Tough War"
New York Times 07/11/2012
Why Monti, despite Merkel, could prove the euro’s best hope - The Washington PostWashington Post 06/24/2012
Pfizer's focus on its core pharmaceutical business in 2011-2015
05/02/2011
Rockoff's interview with Pfizer CEO, Ian Read, in which Read describes his strategy of focussing on new drug development and locating closer to hubs with large universities and research centers such as La Jolla, Cambridge, Massachusetts, and Cambridge, England. Pfizer sold its infant nutrition business to Nestle as part of this plan.
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Life Beyond Lipitor for Pfizer ChiefWall Street Journal 05/02/2011
Research and Development (R&D) approaches of pharmaceutical companies Pfizer and Glaxo with smaller budgets and smaller units
07/01/2010
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Glaxo Tries Biotech Model to Spur Drug InnovationsWall Street Journal 07/01/2010
Roche's integration of Genentech into its operations.
07/24/2008
During the early stages of the acquisition of Genentech questions were raised whether the bigger Swiss compay would end up stifling the research culture at Gennetech and reaearch scientists woul leave. As it turned out few have left and Roche head Severin Schwan has committed Roche to focussing on research as ahuge opportunity for pharmaceuticals as he sees drugmaking still "so crude," and the opportunities vast with advances in biotechnology, diagnostics, and genomics.
Linked Articles
Economist 12/10/2009
Roche's Big Hurdle with GenentechBusinessWeek 07/24/2008
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
